CASI Pharmaceuticals, Inc. (CASIF)
0.1288
0.00 (0.00%)
USD |
OTCM |
Sep 16, 16:00
CASI Pharmaceuticals Max Drawdown (5Y) : 99.54% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 99.54% |
| July 31, 2026 | 99.54% |
| June 30, 2026 | 99.54% |
| May 31, 2026 | 99.54% |
| April 30, 2026 | 99.54% |
| March 31, 2026 | 99.54% |
| February 28, 2026 | 99.18% |
| January 31, 2026 | 98.20% |
| December 31, 2025 | 98.20% |
| November 30, 2025 | 98.20% |
| October 31, 2025 | 98.20% |
| September 30, 2025 | 98.20% |
| August 31, 2025 | 98.20% |
| July 31, 2025 | 98.20% |
| June 30, 2025 | 98.20% |
| May 31, 2025 | 98.20% |
| April 30, 2025 | 98.20% |
| March 31, 2025 | 98.20% |
| February 28, 2025 | 98.20% |
| January 31, 2025 | 98.20% |
| December 31, 2024 | 98.20% |
| November 30, 2024 | 98.20% |
| October 31, 2024 | 98.20% |
| September 30, 2024 | 98.20% |
| August 31, 2024 | 98.20% |
| Date | Value |
|---|---|
| July 31, 2024 | 98.20% |
| June 30, 2024 | 98.20% |
| May 31, 2024 | 98.20% |
| April 30, 2024 | 98.20% |
| March 31, 2024 | 98.20% |
| February 29, 2024 | 98.20% |
| January 31, 2024 | 98.20% |
| December 31, 2023 | 98.20% |
| November 30, 2023 | 98.20% |
| October 31, 2023 | 98.20% |
| September 30, 2023 | 98.20% |
| August 31, 2023 | 98.20% |
| July 31, 2023 | 98.20% |
| June 30, 2023 | 98.20% |
| May 31, 2023 | 98.20% |
| April 30, 2023 | 98.20% |
| March 31, 2023 | 98.20% |
| February 28, 2023 | 98.20% |
| January 31, 2023 | 98.20% |
| December 31, 2022 | 98.20% |
| November 30, 2022 | 97.75% |
| October 31, 2022 | 97.72% |
| September 30, 2022 | 97.13% |
| August 31, 2022 | 97.13% |
| July 31, 2022 | 97.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Sinovac Biotech Ltd. | 25.46% |
| CanSino Biologics, Inc. | 96.53% |
| Shanghai Junshi Biosciences Co., Ltd. | 91.68% |
| Ascletis Pharma, Inc. | 99.73% |
| CStone Pharmaceuticals Co. Ltd. | 95.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -78.36 |
| Beta (5Y) | 1.407 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 108.5% |
| Historical Sharpe Ratio (5Y) | -0.6046 |
| Historical Sortino (5Y) | -1.211 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.35% |